Compare · BMGL vs LFST
BMGL vs LFST
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.82B, about 644.3x BMGL ($7.5M).
- Over the past year, BMGL is down 80.6% and LFST is up 143.2% - LFST leads by 223.8 points.
- LFST has been more active in the news (8 items in the past 4 weeks vs 1 for BMGL).
- LFST has more recent analyst coverage (17 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- LifeStance Health Group Inc.
- Price
- $4.75-5.19%
- $12.60-1.52%
- Market cap
- $7.5M
- $4.82B
- 1M return
- -17.53%
- +5.97%
- 1Y return
- -80.60%
- +143.24%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2021
- News (4w)
- 1
- 8
- Recent ratings
- 0
- 17
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest BMGL
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 3 filed by new insider Neo Alton Chun How
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL to Effect Reverse Share Split on June 22, 2026
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 3 filed by new insider Soong Kwek Yoon
Latest LFST
- LifeStance Health Group Announces Pricing of Secondary Public Offering
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Launch of Secondary Public Offering
- Chief Technology Officer Paunovich Vukasin sold $541,402 worth of shares (42,067 units at $12.87), decreasing direct ownership by 17% to 205,379 units (SEC Form 4)
- Chief Executive Officer Bourdon David disposed of 150,000 shares, decreasing direct ownership by 11% to 1,248,247 units (SEC Form 4)
- LifeStance to Present at Upcoming Investor Conferences
- Chief People Officer Varanakis Ann covered exercise/tax liability with 8,156 shares, decreasing direct ownership by 2% to 413,881 units (SEC Form 4) (for withholding tax)
- Director Deluca Teresa sold $95,100 worth of shares (7,500 units at $12.68), decreasing direct ownership by 7% to 97,093 units (SEC Form 4) (withholding tax)
- Director Deluca Teresa sold $249,993 worth of shares (20,441 units at $12.23), decreasing direct ownership by 16% to 104,593 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.